RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 66 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $20,123 | -9.0% | 13,327 | 0.0% | 0.00% | – |
| Q1 2024 | $22,122 | +3.7% | 13,327 | 0.0% | 0.00% | – |
| Q4 2023 | $21,323 | -94.4% | 13,327 | -73.3% | 0.00% | – |
| Q3 2023 | $379,456 | +8.1% | 49,830 | -6.9% | 0.00% | – |
| Q2 2023 | $351,124 | +58.6% | 53,525 | +44.6% | 0.00% | – |
| Q1 2023 | $221,403 | +491906.7% | 37,024 | +89.4% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 19,552 | +6.2% | 0.00% | – |
| Q3 2022 | $62,000 | – | 18,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $19,298,085 | 47.73% |
| NEA Management Company, LLC | 4,785,494 | $36,441,537 | 2.81% |
| Aisling Capital Management LP | 886,075 | $6,743,031 | 2.78% |
| Octagon Capital Advisors LP | 2,279,870 | $17,361,210 | 2.67% |
| Novo Holdings A/S | 3,330,377 | $25,344,169 | 1.87% |
| GREAT POINT PARTNERS LLC | 1,167,061 | $8,887,170 | 1.62% |
| Carlyle Group Inc. | 2,698,957 | $20,539,063 | 0.89% |
| Eventide Asset Management | 2,078,142 | $15,825,051 | 0.28% |
| Rock Springs Capital Management LP | 1,143,185 | $8,705,354 | 0.23% |
| First Light Asset Management, LLC | 272,317 | $2,073,694 | 0.20% |